[¹⁸F]FDG

Clinical Evaluation	Glucose metabolism
Type of Imaging	PET
Grade of Recommendation	A (strongly recommended)
Level of Evidence	well-established clinical and NM recommendations recommendations
Effective Dose	19.0 µSv/MBq
Bibliographic Reference	Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I,... read more Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Luciani A, Cachin F. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-019-04553-8. NCCN guidelines version 8.2021 https://www.nccn.org/guidelines/nccn-guidelines; Pak, K., Yoon, HJ., Lim, W. et al. Impact of 18F-FDG PET on the management of recurrent breast cancer: a meta-analysis. Clin Transl Imaging 9. 2021; https://doi.org/10.1007/s40336-021-00424-1 read less
Guide to Nuclear Medicine	Read the corresponding chapter

Clinical Evaluation
Glucose metabolism
Type of Imaging
PET
Grade of Recommendation
A (strongly recommended)
Level of Evidence
well-established clinical and NM recommendations recommendations
Effective Dose
19.0 µSv/MBq
Bibliographic Reference
Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I,... read more Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Luciani A, Cachin F. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-019-04553-8. NCCN guidelines version 8.2021 https://www.nccn.org/guidelines/nccn-guidelines; Pak, K., Yoon, HJ., Lim, W. et al. Impact of 18F-FDG PET on the management of recurrent breast cancer: a meta-analysis. Clin Transl Imaging 9. 2021; https://doi.org/10.1007/s40336-021-00424-1 read less
Guide to Nuclear Medicine
Read the corresponding chapter

[18F]FDG